Stephen Dickson, MD
Cardiovascular Disease · Independence, MONPI 1023422474
Payments from drug & device makers
Across 482 payments — averaging $202.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$74K
- Lilly USA, LLC$12K
- Novo Nordisk$5K
- Boston Scientific$1K
- Novartis$977
- Amgen$815
- plus $3K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 92 | $74,118 |
| Lilly USA, LLC | 11 | $12,129 |
| Novo Nordisk | 20 | $5,042 |
| Boston Scientific | 52 | $1,255 |
| Novartis | 78 | $977 |
| Amgen | 55 | $815 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 32 | $549 |
| E.r. Squibb & Sons, L.L.C. | 20 | $360 |
| Johnson & Johnson | 21 | $355 |
| Pfizer | 13 | $323 |
| Merck | 13 | $214 |
| AstraZeneca | 12 | $184 |
| Abiomed | 1 | $144 |
| Sanofi-aventis U.S. LLC | 7 | $114 |
| Vital Connect, Inc | 5 | $100 |
| Lantheus Medical Imaging, Inc. | 4 | $98 |
| Medtronic | 1 | $89 |
| Alnylam Pharmaceuticals Inc. | 5 | $85 |
| Actelion Pharmaceuticals US, Inc. | 5 | $82 |
| Bayer | 4 | $77 |
| Getinge USA Sales, LLC | 1 | $75 |
| Scpharmaceuticals Inc. | 4 | $73 |
| Amarin Pharma, Inc. | 4 | $62 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Philips North America LLC | 3 | $46 |
| Biobeat USA Inc. | 1 | $45 |
| Lemaitre Vascular, Inc. | 1 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $37 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $31 |
| Nuwellis, Inc. | 1 | $29 |
| Atricure, Inc. | 1 | $29 |
| Abbott | 1 | $25 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $22 |
| Sanofi | 1 | $20 |
| Terumo Medical Corporation | 1 | $19 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$97,810 in reported general payments places this provider in the 90th percentile of 391 cardiovascular disease providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Independence
- Mikhail KosiborodKansas City$27.8M
- Mohammad TahirSaint Louis$2.7M
- John SpertusKansas City$2.3M
- Joshua MitchellSaint Louis$1.4M
- Nathan StitzielSaint Louis$1.2M
- Daniel KellySaint Louis$1.1M
- Georges ChahoudSaint Louis$967K
- Jiafu OuSaint Louis$853K
- William BowenSaint Louis$726K
- Omar AlmousalliFestus$690K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.